CLINICAL_TRIALS
trial_result
· 2024-08-14
Clinical Trial Update: NOVOCART® Inject Plus for Cartilage Defects of the Knee [Phase 3]
Summary
This update reports that a Phase 3 study of NOVOCART Inject Plus for cartilage defects of the knee has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tetec AG | Conditions: Cartilage Defects of the Knee | Phase 3 | Status: COMPLETED